These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8219364)

  • 41. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [What glycemic control can be achieved in young diabetics without residual secretion of endogenous insulin? What is the frequency of severe hypoglycemia and subclinical complications?].
    Dorchy H
    Arch Pediatr; 1994 Nov; 1(11):970-81. PubMed ID: 7834046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of improved glycaemic control on rates of hypoglycaemia in insulin dependent diabetes mellitus.
    Davis EA; Keating B; Byrne GC; Russell M; Jones TW
    Arch Dis Child; 1998 Feb; 78(2):111-5. PubMed ID: 9579150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of glycaemic control and hypoglycaemia in children and adolescents with type 1 diabetes from NSW and the ACT.
    Craig ME; Handelsman P; Donaghue KC; Chan A; Blades B; Laina R; Bradford D; Middlehurst A; Ambler G; Verge CF; Crock P; Moore P; Silink M;
    Med J Aust; 2002 Sep; 177(5):235-8. PubMed ID: 12197816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment with the insulin analogue lispro in children and adolescents with type 1 diabetes mellitus: evaluation over a 3-year period.
    García L; Lamas C; Tuset MJ; Alonso M; Barrio R
    Diabetes Nutr Metab; 2002 Feb; 15(1):7-13. PubMed ID: 11942742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study.
    Cengiz E; Cheng P; Ruedy KJ; Kollman C; Tamborlane WV; Klingensmith GJ; Gal RL; Silverstein J; Lee J; Redondo MJ; Beck RW;
    Pediatr Diabetes; 2017 Nov; 18(7):566-573. PubMed ID: 27758023
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control?
    Nixon R; Pickup JC
    Diabetes Technol Ther; 2011 Feb; 13(2):93-8. PubMed ID: 21284474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial.
    Fanelli CG; Pampanelli S; Porcellati F; Rossetti P; Brunetti P; Bolli GB
    Ann Intern Med; 2002 Apr; 136(7):504-14. PubMed ID: 11926785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved glycemic control and lower frequency of severe hypoglycemia with insulin detemir; long-term experience in 105 children and adolescents with type 1 diabetes.
    Braun D; Konrad D; Lang-Muritano M; Schoenle E
    Pediatr Diabetes; 2008 Aug; 9(4 Pt 2):382-7. PubMed ID: 18331413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors associated with glycemic control. A cross-sectional nationwide study in 2,579 French children with type 1 diabetes. The French Pediatric Diabetes Group.
    Rosilio M; Cotton JB; Wieliczko MC; Gendrault B; Carel JC; Couvaras O; Ser N; Gillet P; Soskin S; Garandeau P; Stuckens C; Le Luyer B; Jos J; Bony-Trifunovic H; Bertrand AM; Leturcq F; Lafuma A; French Pediatric Diabetes Group ; Bougnères PF
    Diabetes Care; 1998 Jul; 21(7):1146-53. PubMed ID: 9653610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial.
    Heller S; Koenen C; Bode B
    Clin Ther; 2009 Oct; 31(10):2086-97. PubMed ID: 19922879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does Reducing Basal Insulin During Ramadan Fasting by Children and Adolescents with Type 1 Diabetes Decrease the Risk of Symptomatic Hypoglycemia?
    Deeb A; Al Qahtani N; Attia S; Al Suwaidi H; Nagelkerke N
    Diabetes Technol Ther; 2016 Sep; 18(9):539-42. PubMed ID: 27500913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Retrospective analysis of the incidence of severe hypoglycemia in 458 type 1 diabetic patients].
    Bali C; Gurdet C; Irsigler K
    Acta Med Austriaca; 1997; 24(5):165-9. PubMed ID: 9480616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia.
    Johansen OE; Vanberg PJ; Kilhovd BK; Jørgensen AP
    Vasc Health Risk Manag; 2009; 5(1):121-8. PubMed ID: 19436668
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Severe hypoglycemia in children with insulin-dependent diabetes mellitus: frequency and predisposing factors.
    Daneman D; Frank M; Perlman K; Tamm J; Ehrlich R
    J Pediatr; 1989 Nov; 115(5 Pt 1):681-5. PubMed ID: 2491424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
    Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
    JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.
    Am J Med; 1991 Apr; 90(4):450-9. PubMed ID: 2012085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired awareness of hypoglycemia in children and adolescents with type 1 diabetes mellitus in north of Jordan.
    Alkhatatbeh MJ; Abdalqader NA; Alqudah MAY
    BMC Endocr Disord; 2019 Oct; 19(1):107. PubMed ID: 31651281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group.
    Holleman F; Schmitt H; Rottiers R; Rees A; Symanowski S; Anderson JH
    Diabetes Care; 1997 Dec; 20(12):1827-32. PubMed ID: 9405901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-term Randomized Controlled Trial in Adolescents With Type 1 Diabetes.
    Abraham MB; Nicholas JA; Smith GJ; Fairchild JM; King BR; Ambler GR; Cameron FJ; Davis EA; Jones TW;
    Diabetes Care; 2018 Feb; 41(2):303-310. PubMed ID: 29191844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.